3LRH | Immune System | date | Feb 11, 2010 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Structure Of Anti-Huntingtin Vl Domain In Complex With Hunti Peptide | ||||||||||||||
authors | A.Schiefner, L.Chatwell, A.Skerra | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Anti-Huntingtin Vl Domain Chain: A, C, E, G, I, K, M, O Fragment: Anti-Huntingtin Vl Domain Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_taxid: 9606 Strain: Phage Display Library Synthetic Gene: Vl12.3 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Jm83 Expression_system_vector_type: Plasmid Expression_system_plasmid: Pask75(T7rbs)His | ||||||||||||||
Molecule: Huntingtin Chain: B, D, F, H, J, L, N, P Fragment: Huntingtin Peptide Synonym: Huntington Disease Protein, Hd Protein Engineered: Yes |
Synthetic: Yes Other_details: The Huntingtin Fragment 5-18 Was Obtained By Synthesis. This Sequence Occurs Naturally In Humans. | ||||||||||||||
symmetry | Space Group: P 1 21 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.60 Å | ||||||||||||
Primary reference | A Disulfide-Free Single-Domain V(L) Intrabody with Blocking Activity towards Huntingtin Reveals a Novel Mode of Epitope Recognition., Schiefner A, Chatwell L, Korner J, Neumaier I, Colby DW, Volkmer R, Wittrup KD, Skerra A, J Mol Biol. 2011 Sep 24. PMID:21968397 |
Data retrieval |
View 3LRH in 3D |
Visual 3D analysis of 3LRH |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3LRH |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |